Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.

Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH.

J Virol. 2008 Jul;82(14):6829-37. doi: 10.1128/JVI.00353-08. Epub 2008 Apr 30.

2.

Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.

Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.

J Virol. 2008 Apr;82(7):3517-29. doi: 10.1128/JVI.01854-07. Epub 2008 Jan 16.

3.

Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.

Clark KM, Johnson JB, Kock ND, Mizel SB, Parks GD.

Virology. 2011 Oct 25;419(2):97-106. doi: 10.1016/j.virol.2011.08.005. Epub 2011 Aug 31.

5.

Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.

Golden JW, Josleyn MD, Hooper JW.

Vaccine. 2008 Jun 25;26(27-28):3507-15. doi: 10.1016/j.vaccine.2008.04.017. Epub 2008 Apr 28.

PMID:
18485547
6.
7.

Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.

Bissa M, Pacchioni SM, Zanotto C, De Giuli Morghen C, Illiano E, Granucci F, Zanoni I, Broggi A, Radaelli A.

Virus Res. 2013 Dec 26;178(2):374-82. doi: 10.1016/j.virusres.2013.09.016. Epub 2013 Sep 16.

PMID:
24050999
8.

Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.

Braxton CL, Puckett SH, Mizel SB, Lyles DS.

J Virol. 2010 Apr;84(7):3552-61. doi: 10.1128/JVI.01572-09. Epub 2010 Jan 20.

10.

Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.

Meseda CA, Campbell J, Kumar A, Garcia AD, Merchlinsky M, Weir JP.

PLoS One. 2013 Jun 13;8(6):e67984. doi: 10.1371/journal.pone.0067984. Print 2013.

11.

Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity.

Bissa M, Quaglino E, Zanotto C, Illiano E, Rolih V, Pacchioni S, Cavallo F, De Giuli Morghen C, Radaelli A.

Antiviral Res. 2016 Oct;134:182-191. doi: 10.1016/j.antiviral.2016.09.002. Epub 2016 Sep 13.

12.

A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.

Xiao Y, Aldaz-Carroll L, Ortiz AM, Whitbeck JC, Alexander E, Lou H, Davis HL, Braciale TJ, Eisenberg RJ, Cohen GH, Isaacs SN.

Vaccine. 2007 Jan 26;25(7):1214-24. Epub 2006 Oct 17.

13.

L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines.

Pacchioni SM, Bissa M, Zanotto C, Morghen Cde G, Illiano E, Radaelli A.

J Transl Med. 2013 Apr 11;11:95. doi: 10.1186/1479-5876-11-95.

14.

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.

Galmiche MC, Goenaga J, Wittek R, Rindisbacher L.

Virology. 1999 Feb 1;254(1):71-80.

15.
16.

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.

Hooper JW, Custer DM, Schmaljohn CS, Schmaljohn AL.

Virology. 2000 Jan 20;266(2):329-39.

17.

Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.

Sakhatskyy P, Wang S, Zhang C, Chou TH, Kishko M, Lu S.

Virology. 2008 Feb 5;371(1):98-107. Epub 2007 Oct 24.

18.

Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.

Paran N, Lustig S, Zvi A, Erez N, Israely T, Melamed S, Politi B, Ben-Nathan D, Schneider P, Lachmi B, Israeli O, Stein D, Levin R, Olshevsky U.

Virol J. 2013 Jul 10;10:229. doi: 10.1186/1743-422X-10-229.

19.

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.

Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB.

J Virol. 2004 May;78(9):4433-43.

20.

An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.

Morikawa S, Sakiyama T, Hasegawa H, Saijo M, Maeda A, Kurane I, Maeno G, Kimura J, Hirama C, Yoshida T, Asahi-Ozaki Y, Sata T, Kurata T, Kojima A.

J Virol. 2005 Sep;79(18):11873-91.

Supplemental Content

Support Center